Javascript must be enabled to continue!
Exploring Varicella Vaccine Coverage and Influencing Factors in Rural and Pastoral Children of Qinghai Province: A Cross-Sectional Catch-Up Vaccination Study
View through CrossRef
<i>Background: </i>Varicella is a respiratory infectious disease caused by varicella-zoster virus (VZV) infection. Varicella vaccine has been shown to be highly effective in preventing varicella disease, however it is not included in Qinghai Province’s local immunization planning program and must be paid for by families. Its use in local areas is options instead of compulsory, so high coverage is difficult to guarantee. Starting in October 2021, one dose of live attenuated varicella vaccine was recommended at lest for 3-17-year-old children in Qinghai. In 2022, it was conducted that an investigation of varicella vaccine coverage and factors influencing coverage among children in rural rural and pastoral areas to determine the impact of this VarV catch-up policy. <i>Objective: </i> To explore varicella vaccine coverage and factors influencing caverage among 3-17-year-old children in rural and pastoral areas of Qinghai province. <i>Methods:</i> A stratified cluster sampling method was used to select children aged 3-17 years from kindergartens and primary /secondary schools in rural and pastoral areas of Qinghai province for a questionnaire-based survey of their guardians. Coverage levels of one and two doses of VarV (VarV<sub>1</sub> and VarV<sub>2</sub>) before and after a catch-up vaccination activity initiated in October 2021, and identified factors influenceing VarV<sub>1</sub> coverage. <i>Results:</i> VarV<sub>1</sub> and VarV<sub>2 </sub>coverage levels after the catch-up activity were 79.06% (676/855) and 43.79% (363/829), respectively, and increased by 34.38 and 24.13 percentage points compared with before the catch-up activity. Multivariate logistic regression showed that VarV<sub>1 </sub>coverage was higher in rural areas than in pastoral areas (OR=4.63, 95%<I>CI</I>: 2.91-7.39), and higher among children whose guardians scored 4-6 or 7-10 points on knowledge about varicella and VarV than among children whose guardians scored 0-3 points (OR=8.61, 95%<I>CI</I>: 4.73-15.69, OR=2.86, 95%<I>CI</I>: 1.69-4.84). the main reasons for non-vaccination were guardians’ lack of understanding of VarV (48.6%, 87 children), guardians’ unawarness of the need for VarV vaccination (43.6%, 78 children), and unavailability of VarV at vaccination centers (31.3%, 56 children). <i>Conclusions: </i>The catch-up activity significantly increased VarV coverage among children in the surveyed areas. It should been strengthened that health education on knowledge about varicella and VarV among guardians of children in Qinghai, especially in pastoral areas, to promote VarV vaccination of age-eligible children.
Science Publishing Group
Title: Exploring Varicella Vaccine Coverage and Influencing Factors in Rural and Pastoral Children of Qinghai Province: A Cross-Sectional Catch-Up Vaccination Study
Description:
<i>Background: </i>Varicella is a respiratory infectious disease caused by varicella-zoster virus (VZV) infection.
Varicella vaccine has been shown to be highly effective in preventing varicella disease, however it is not included in Qinghai Province’s local immunization planning program and must be paid for by families.
Its use in local areas is options instead of compulsory, so high coverage is difficult to guarantee.
Starting in October 2021, one dose of live attenuated varicella vaccine was recommended at lest for 3-17-year-old children in Qinghai.
In 2022, it was conducted that an investigation of varicella vaccine coverage and factors influencing coverage among children in rural rural and pastoral areas to determine the impact of this VarV catch-up policy.
<i>Objective: </i> To explore varicella vaccine coverage and factors influencing caverage among 3-17-year-old children in rural and pastoral areas of Qinghai province.
<i>Methods:</i> A stratified cluster sampling method was used to select children aged 3-17 years from kindergartens and primary /secondary schools in rural and pastoral areas of Qinghai province for a questionnaire-based survey of their guardians.
Coverage levels of one and two doses of VarV (VarV<sub>1</sub> and VarV<sub>2</sub>) before and after a catch-up vaccination activity initiated in October 2021, and identified factors influenceing VarV<sub>1</sub> coverage.
<i>Results:</i> VarV<sub>1</sub> and VarV<sub>2 </sub>coverage levels after the catch-up activity were 79.
06% (676/855) and 43.
79% (363/829), respectively, and increased by 34.
38 and 24.
13 percentage points compared with before the catch-up activity.
Multivariate logistic regression showed that VarV<sub>1 </sub>coverage was higher in rural areas than in pastoral areas (OR=4.
63, 95%<I>CI</I>: 2.
91-7.
39), and higher among children whose guardians scored 4-6 or 7-10 points on knowledge about varicella and VarV than among children whose guardians scored 0-3 points (OR=8.
61, 95%<I>CI</I>: 4.
73-15.
69, OR=2.
86, 95%<I>CI</I>: 1.
69-4.
84).
the main reasons for non-vaccination were guardians’ lack of understanding of VarV (48.
6%, 87 children), guardians’ unawarness of the need for VarV vaccination (43.
6%, 78 children), and unavailability of VarV at vaccination centers (31.
3%, 56 children).
<i>Conclusions: </i>The catch-up activity significantly increased VarV coverage among children in the surveyed areas.
It should been strengthened that health education on knowledge about varicella and VarV among guardians of children in Qinghai, especially in pastoral areas, to promote VarV vaccination of age-eligible children.
Related Results
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US
Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US
Background
In 1995, the CDC recommended one-dose routine varicella immunization for children <12 years of age, expanding its recommendation to two doses in 2006. Today, with wid...
Varicella and Zoster in Children After Kidney Transplantation: Long-term Results of Vaccination
Varicella and Zoster in Children After Kidney Transplantation: Long-term Results of Vaccination
Objective. To determine the long-term prevalence of varicella infection and herpes zoster after kidney transplantation and to assess the effectiveness of varicella immunization wit...
#6: Varicella Outbreak Investigation in a Cancer Hospital
#6: Varicella Outbreak Investigation in a Cancer Hospital
Abstract
Background
Primary varicella infection is usually self-limited in immunocompetent hosts, whereas it can be quite severe...
Measles Vaccination Coverage and Protective Effectiveness in the Amhara Regional State, Ethiopia, 2019-2024
Measles Vaccination Coverage and Protective Effectiveness in the Amhara Regional State, Ethiopia, 2019-2024
Abstract
Background:
Despite the availability of an effective vaccine, measles remains a major public health problem in Ethiopi...
Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19
Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19
Abstract
This paper uses large cross-country data for 110 countries to examine the effectiveness of COVID vaccination coverage. Our results confirm that vaccines ar...
EPIDEMIOLOGICAL CHARACTERISTICS OF VARICELLA IN KON TUM PROVINCE IN 2018
EPIDEMIOLOGICAL CHARACTERISTICS OF VARICELLA IN KON TUM PROVINCE IN 2018
Abstract:
Background: In Vietnam, the number of people suffered from Varicella was high, accounting for 25.000 – 40.000 cases and children were dominant. In Kon Tum, the annual num...
Varicella and Zoster (Shingles)
Varicella and Zoster (Shingles)
A live attenuated vaccine against varicella (later also used to prevent zoster) was developed in 1974 by Takahashi and colleagues.
Varicella vaccine was licensed for universal imm...

